Elevance Health, Inc. (ELV) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $21.18B | +7.2% |
| 2024 | $19.75B | +14.2% |
| 2023 | $17.29B | +32.7% |
| 2022 | $13.04B | +19.6% |
| 2021 | $10.89B | +21.7% |
| 2020 | $8.95B | +349.4% |
| 2019 | $1.99B | — |
| 2018 | $0 | — |
| 2017 | $0 | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $21.18B | +7.2% |
| 2024 | $19.75B | +14.2% |
| 2023 | $17.29B | +32.7% |
| 2022 | $13.04B | +19.6% |
| 2021 | $10.89B | +21.7% |
| 2020 | $8.95B | +349.4% |
| 2019 | $1.99B | — |
| 2018 | $0 | — |
| 2017 | $0 | — |